KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Cvs Health's Income from Continuing Operations rose 8009.86% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year decrease of 6232.01%. This contributed to the annual value of $1.7 billion for FY2025, which is 6232.01% down from last year.
  • According to the latest figures from Q4 2025, Cvs Health's Income from Continuing Operations is $2.9 billion, which was up 8009.86% from -$4.0 billion recorded in Q3 2025.
  • Cvs Health's Income from Continuing Operations' 5-year high stood at $3.0 billion during Q2 2022, with a 5-year trough of -$4.0 billion in Q3 2025.
  • Moreover, its 5-year median value for Income from Continuing Operations was $1.8 billion (2023), whereas its average is $1.3 billion.
  • Per our database at Business Quant, Cvs Health's Income from Continuing Operations surged by 16663.72% in 2023 and then tumbled by 571971.83% in 2025.
  • Over the past 5 years, Cvs Health's Income from Continuing Operations (Quarter) stood at $1.4 billion in 2021, then surged by 68.13% to $2.3 billion in 2022, then fell by 12.22% to $2.0 billion in 2023, then fell by 20.71% to $1.6 billion in 2024, then surged by 80.1% to $2.9 billion in 2025.
  • Its last three reported values are $2.9 billion in Q4 2025, -$4.0 billion for Q3 2025, and $1.0 billion during Q2 2025.